Kobelt, G.; Lindgren, P.; Young, A. - In: The European Journal of Health Economics 3 (2002) 3, pp. 180-187
This study investigated the cost-effectiveness of leflunomide (LEF) compared to methotrexate (MTX) and sulfasalazine … (SSZ) in the United Kingdom. A Markov model was constructed using health states defined by Health Assessment Questionnaire … was reversed (£34,070 and 4.487 QALYs for MTX compared to £36,351 and 4.372 QALYs for LEF). Compared to SSZ, the cost of …